Last updated: 24 July 2019 at 7:22pm EST

David Fronk Net Worth




The estimated Net Worth of David Fronk is at least $2.22 Milion dollars as of 16 February 2015. David Fronk owns over 15,000 units of Artivion Inc stock worth over $2,142,543 and over the last 20 years David sold CRY stock worth over $77,077.

David Fronk CRY stock SEC Form 4 insiders trading

David has made over 9 trades of the Artivion Inc stock since 2007, according to the Form 4 filled with the SEC. Most recently David exercised 15,000 units of CRY stock worth $145,950 on 16 February 2015.

The largest trade David's ever made was exercising 30,800 units of Artivion Inc stock on 17 May 2007 worth over $67,760. On average, David trades about 2,794 units every 69 days since 2004. As of 16 February 2015 David still owns at least 119,829 units of Artivion Inc stock.

You can see the complete history of David Fronk stock trades at the bottom of the page.



What's David Fronk's mailing address?

David's mailing address filed with the SEC is CRYOLIFE, INC., 1655 ROBERTS BLVD., NW, KENNESAW, GA, 30144.

Insiders trading at Artivion Inc

Over the last 21 years, insiders at Artivion Inc have traded over $18,346,910 worth of Artivion Inc stock and bought 91,700 units worth $1,086,548 . The most active insiders traders include Steven G Anderson, Thomas F Ackerman a James P Mackin. On average, Artivion Inc executives and independent directors trade stock every 26 days with the average trade being worth of $211,842. The most recent stock trade was executed by Amy Horton on 8 December 2021, trading 2,500 units of CRY stock currently worth $46,425.



What does Artivion Inc do?

Headquartered in suburban Atlanta, Georgia, CryoLife is a leader in the manufacturing, processing, and distribution of medical devices and implantable tissues used in cardiac and vascular surgical procedures focused on aortic repair. CryoLife markets and sells products in more than 100 countries worldwide.



Complete history of David Fronk stock trades at Artivion Inc

Osoba
Trans.
Transakce
Celková cena
David Fronk
VP - Clinical Research
Využití opce $145,950
16 Feb 2015
David Fronk
VP - Clinical Research
Prodej $77,077
16 May 2014
David Fronk
VP - Clinical Research
Využití opce $88,148
12 Nov 2013
David Fronk
VP - Clinical Research
Využití opce $42,352
8 Nov 2013
David Fronk
VP - Clinical Research
Využití opce $109,521
7 Feb 2012
David Fronk
VP - Clinical Research
Využití opce $58,480
26 Jul 2011
David Fronk
VP - Clinical Research
Využití opce $16,940
29 Jan 2008
David Fronk
VP - Clinical Research
Využití opce $20,798
12 Jun 2007
David Fronk
VP - Clinical Research
Využití opce $67,760
17 May 2007


Artivion Inc executives and stock owners

Artivion Inc executives and other stock owners filed with the SEC include: